Antithrombotic agents in cerebral ischaemia.
Article
Dans Anglais
| IMSEAR
| ID: sea-85138
ABSTRACT
The current evidence suggests that aspirin is treatment of choice when compared to anticoagulants for patients with non-cardioembolic stroke. The usefulness of combination therapy (aspirin vs. with or without warfarin) is still debated. Likewise the combination of Aspirin with clopidogrel has no added advantage (MATCH Trial). However anticoagulant therapy significantly benefits high-risk patients with atrial fibrillation in the elderly subjects whereas aspirin may still be the drug of choice in stroke prevention in low risk group in the younger age. There is dire need for well planned randomized double blind controlled studies to define the role of Antithrombotic agents in "cryptogenic stroke" (PFO/ASD related) antiphospholipid antibody syndrome, arterial dissections and intraluminal clot syndromes. Evaluation and treatment of associated risk factors in all categories needs greater emphasis.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Humains
/
Encéphalopathie ischémique
/
Acide acétylsalicylique
/
Facteurs de risque
/
Appréciation des risques
/
Accident vasculaire cérébral
/
Fibrinolytiques
/
Anticoagulants
Type d'étude:
Essai clinique contrôlé
/
Etude d'étiologie
/
Facteurs de risque
langue:
Anglais
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS